Sorbent Therapeutics Secures $18,056,217 New Funding Round

  • Feed Type
  • Date
    8/8/2012
  • Company Name
    Sorbent Therapeutics
  • Mailing Address
    710 Lakeway Drive Sunnyvale, CA 94085
  • Company Description
    Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension.
  • Website
    http://www.sorbentrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,056,217
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.